Iron status and the treatment of the anemia of prematurity

Pamela J. Kling, Joy Winzerling

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

Original languageEnglish (US)
Pages (from-to)283-294
Number of pages12
JournalClinics in Perinatology
Volume29
Issue number2
DOIs
StatePublished - 2002

Fingerprint

Anemia
Iron
Erythrocyte Transfusion
Premature Infants
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Iron status and the treatment of the anemia of prematurity. / Kling, Pamela J.; Winzerling, Joy.

In: Clinics in Perinatology, Vol. 29, No. 2, 2002, p. 283-294.

Research output: Contribution to journalArticle

@article{eb019a4cfe4f47b598b17135a57108f7,
title = "Iron status and the treatment of the anemia of prematurity",
abstract = "Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.",
author = "Kling, {Pamela J.} and Joy Winzerling",
year = "2002",
doi = "10.1016/S0095-5108(02)00002-7",
language = "English (US)",
volume = "29",
pages = "283--294",
journal = "Clinics in Perinatology",
issn = "0095-5108",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Iron status and the treatment of the anemia of prematurity

AU - Kling, Pamela J.

AU - Winzerling, Joy

PY - 2002

Y1 - 2002

N2 - Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

AB - Many unanswered issues regarding rhEPO therapy in prematurity remain, including which premature infants best respond to rhEPO, what the long-term effect of decreased erythrocyte transfusions is, how nutritional supplementation optimizes the effect of rhEPO, whether or not rhEpo therapy causes iron deficiency later in life, and whether or not it is safe to supplement with parenteral iron. Further study of rhEPO therapy and iron status in prematurity is necessary.

UR - http://www.scopus.com/inward/record.url?scp=0035990692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035990692&partnerID=8YFLogxK

U2 - 10.1016/S0095-5108(02)00002-7

DO - 10.1016/S0095-5108(02)00002-7

M3 - Article

C2 - 12168242

AN - SCOPUS:0035990692

VL - 29

SP - 283

EP - 294

JO - Clinics in Perinatology

JF - Clinics in Perinatology

SN - 0095-5108

IS - 2

ER -